Analysis of megakaryocyte ploidy in patients with thrombocytosis

Int J Cell Cloning. 1990 Jul;8(4):299-306. doi: 10.1002/stem.5530080415.

Abstract

The DNA content of bone marrow megakaryocytes was analyzed in 24 patients with myeloproliferative disorders, 23 patients with secondary thrombocytosis and 15 normal volunteers using 2-color flow cytometry. Compared with normal controls, the majority of patients with secondary thrombocytosis, polycythemia vera and essential thrombocytosis exhibited a relative increase in higher ploidy (greater than 16N) cells. In contrast, patients with chronic myelogenous leukemia exhibited an increase in lower ploidy cells (less than 16N), with a modal DNA content of 8N. Patients with myeloproliferative disorders tended to show a decrease in the 16N megakaryocyte population compared with patients with secondary thrombocytosis. No correlation between ploidy distribution and platelet count was observed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Bone Marrow / pathology
  • Flow Cytometry
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Megakaryocytes / pathology*
  • Myeloproliferative Disorders / genetics
  • Myeloproliferative Disorders / pathology
  • Ploidies*
  • Reference Values
  • Thrombocytosis / genetics
  • Thrombocytosis / pathology*